☰

Megan E. Muroski - Publications

Affiliations: 
Northwestern University, Evanston, IL 
Area:
nanoparticles, neuro oncology
Tree Info Similar researchers PubMed Report error

21 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2020 Caragher S, Miska J, Shireman J, Park CH, Muroski M, Lesniak MS, Ahmed AU. Temozolomide Treatment Increases Fatty Acid Uptake in Glioblastoma Stem Cells. Cancers. 12. PMID 33114573 DOI: 10.3390/cancers12113126  0.348
2020 Nag OK, Muroski ME, Hastman DA, Almeida B, Medintz IL, Huston AL, Delehanty JB. Nanoparticle-Mediated Visualization and Control of Cellular Membrane Potential: Strategies, Progress, and Remaining Issues. Acs Nano. PMID 32078291 DOI: 10.1021/Acsnano.9B10163  0.398
2020 Muroski M, Oh E, Nag OK, Medintz IL, Efros AL, Huston AL, Delehanty JB. Gold Nanoparticle-Mediated Depolarization of Membrane Potential is Dependent on Concentration and Tethering Distance from the Plasma Membrane. Bioconjugate Chemistry. PMID 31894966 DOI: 10.1021/Acs.Bioconjchem.9B00656  0.342
2019 Muroski ME, Oh E, Deschamps J, Delehanty JB. Gold Nanoparticle Bioconjugates: Display of Potassium Channel–Blocking Tertiapin‐Q Peptides on Gold Nanoparticles Enhances Depolarization of Cellular Membrane Potential (Part. Part. Syst. Charact. 3/2019) Particle & Particle Systems Characterization. 36: 1970007. DOI: 10.1002/Ppsc.201970007  0.415
2019 Muroski ME, Oh E, Deschamps J, Delehanty JB. Display of Potassium Channel–Blocking Tertiapin‐Q Peptides on Gold Nanoparticles Enhances Depolarization of Cellular Membrane Potential Particle & Particle Systems Characterization. 36: 1800493. DOI: 10.1002/Ppsc.201800493  0.411
2018 Wu C, Muroski ME, Miska J, Lee-Chang C, Shen Y, Rashidi A, Zhang P, Xiao T, Han Y, Lopez-Rosas A, Cheng Y, Lesniak MS. Repolarization of myeloid derived suppressor cells via magnetic nanoparticles to promote radiotherapy for glioma treatment. Nanomedicine : Nanotechnology, Biology, and Medicine. PMID 30553919 DOI: 10.1016/J.Nano.2018.11.015  0.434
2018 Carnevale KJF, Muroski ME, Vakil PN, Foley ME, Laufersky G, Kenworthy R, Zorio DAR, Morgan TJ, Levenson CW, Strouse GF. Selective Uptake Into Drug Resistant Mammalian Cancer By Cell Penetrating Peptide-Mediated Delivery. Bioconjugate Chemistry. PMID 30240193 DOI: 10.1021/Acs.Bioconjchem.8B00429  0.415
2017 Muroski ME, Miska J, Chang AL, Zhang P, Rashidi A, Moore H, Lopez-Rosas A, Han Y, Lesniak MS. Fatty Acid Uptake in T Cell Subsets Using a Quantum Dot Fatty Acid Conjugate. Scientific Reports. 7: 5790. PMID 28724939 DOI: 10.1038/S41598-017-05556-X  0.378
2017 Feng Q, Shen Y, Fu Y, Muroski ME, Zhang P, Wang Q, Xu C, Lesniak MS, Li G, Cheng Y. Self-Assembly of Gold Nanoparticles Shows Microenvironment-Mediated Dynamic Switching and Enhanced Brain Tumor Targeting. Theranostics. 7: 1875-1889. PMID 28638474 DOI: 10.7150/Thno.18985  0.436
2016 Spencer DA, Auffinger BM, Murphy JP, Muroski ME, Qiao J, Govind Y, Lesniak MS. Hitting a Moving Target: Glioma Stem Cells Demand New Approaches in Glioblastoma Therapy. Current Cancer Drug Targets. PMID 27993114 DOI: 10.2174/1568009616666161215161924  0.404
2016 Miska J, Rashidi A, Chang AL, Muroski ME, Han Y, Zhang L, Lesniak MS. Anti-GITR therapy promotes immunity against malignant glioma in a murine model. Cancer Immunology, Immunotherapy : Cii. PMID 27734112 DOI: 10.1007/S00262-016-1912-8  0.315
2016 Morshed RA, Muroski ME, Dai Q, Wegscheid ML, Auffinger B, Yu D, Han Y, Zhang L, Wu M, Cheng Y, Lesniak MS. Cell penetrating peptide-modified gold nanoparticles for the delivery of doxorubicin to brain metastatic breast cancer. Molecular Pharmaceutics. PMID 27169484 DOI: 10.1021/Acs.Molpharmaceut.6B00004  0.47
2016 Muroski ME, Morshed RA, Cheng Y, Vemulkar T, Mansell R, Han Y, Zhang L, Aboody KS, Cowburn RP, Lesniak MS. Controlled Payload Release by Magnetic Field Triggered Neural Stem Cell Destruction for Malignant Glioma Treatment. Plos One. 11: e0145129. PMID 26734932 DOI: 10.1371/Journal.Pone.0145129  0.371
2015 Cheng Y, Muroski ME, Petit DC, Mansell R, Vemulkar T, Morshed RA, Han Y, Balyasnikova I, Horbinski C, Huang X, Zhang L, Cowburn RP, Lesniak MS. Rotating magnetic field induced oscillation of magnetic particles for in vivo mechanical destruction of malignant glioma. Journal of Controlled Release : Official Journal of the Controlled Release Society. PMID 26708022 DOI: 10.1016/J.Jconrel.2015.12.028  0.308
2015 Yan Y, Sart S, Calixto Bejarano F, Muroski ME, Strouse GF, Grant SC, Li Y. Cryopreservation of embryonic stem cell-derived multicellular neural aggregates labeled with micron-sized particles of iron oxide for magnetic resonance imaging. Biotechnology Progress. 31: 510-21. PMID 25905549 DOI: 10.1002/Btpr.2049  0.569
2015 Muroski ME, Carnevale KJ, Riskowski RA, Strouse GF. Plasmid transfection in mammalian cells spatiotemporally tracked by a gold nanoparticle. Acs Nano. 9: 124-33. PMID 25494916 DOI: 10.1021/Nn5060305  0.628
2015 Muroski ME, Carnevale KJF, Riskowski RA, Strouse GF. Plasmid transfection in mammalian cells spatiotemporally tracked by a gold nanoparticle Acs Nano. 9: 124-133. DOI: 10.1021/nn5060305  0.576
2014 Muroski ME, Morgan TJ, Levenson CW, Strouse GF. A gold nanoparticle pentapeptide: gene fusion to induce therapeutic gene expression in mesenchymal stem cells. Journal of the American Chemical Society. 136: 14763-71. PMID 25198921 DOI: 10.1021/Ja505190Q  0.628
2013 Tanasova M, Plutschack M, Muroski ME, Sturla SJ, Strouse GF, McQuade DT. Fluorescent THF-based fructose analogue exhibits fructose-dependent uptake. Chembiochem : a European Journal of Chemical Biology. 14: 1263-70. PMID 23784717 DOI: 10.1002/Cbic.201300164  0.583
2012 Muroski ME, Kogot JM, Strouse GF. Bimodal gold nanoparticle therapeutics for manipulating exogenous and endogenous protein levels in mammalian cells Journal of the American Chemical Society. 134: 19722-19730. PMID 23131062 DOI: 10.1021/Ja307502X  0.635
2002 Chakrabarti R, Robles LD, Gibson J, Muroski M. Profiling of differential expression of messenger RNA in normal, benign, and metastatic prostate cell lines. Cancer Genetics and Cytogenetics. 139: 115-25. PMID 12550771 DOI: 10.1016/S0165-4608(02)00641-6  0.324
Show low-probability matches.